Women in treatment in the Czech Republic

Běla Studničková, M. D., Vladimír Polanecký, M. D.Drug Epidemiology Headquarters

Hygienic Station of the Capital Prague

Women in treatment in the Czech Republic

System of data collection

Data provider = TC centres

Data collection provides Hygienic Service

National sumary of data and data analysis provides Drug Epidemiology Headquarters of the Hygienic Station of the Capital Prague

EMCDDA form is used

monitoring of incidence of treated drug users (First Treatment Demand – FTD) since 1.1.1995

monitoring of prevalence of treated drug users and All Treatment Demand (ATD) since 1.1.2002

Women in treatment in the Czech Republic

AgeSexDistrict of T/CDistrict of livingSource of referral Current living status Employment status Highest education level

Primary and secondary drugsRoute of AdministrationFrequency of useDuration of regular useRisk behaviour:

Curently or ever injected Shared past month or ever HIV and VH status

Initial outcome

Collected data:

Women in treatment in the Czech Republic - 2003 The age distribution of treated drug users according to sex

Age group Men Women Men : women

ratio Total %

Prevalence of women / 100 000 women

Under 15 71 38 1,9 : 1 109 1,3 4,9 15 - 19 1386 1042 1,3 : 1 2432 28,5 319,0

20 - 24 2015 918 2,2 : 1 2934 34,4 236,9

25 - 39 2142 584 3,7 : 1 2727 32,0 51,7

40 and more 208 48 4,3 : 1 256 3,0 1,8

Unknown 43 16 2,7 : 1 64 0,8 *

Total 5865 2646 2,2 : 1 8522 100 50,5

Prevalence in the year 2003

Incidence (FTD) in the year 2003

Age group Men Women Men : women

ratio Total %

Incidence of women / 100 000 women

Under 15 57 35 1,6 : 1 92 2,2 4,5 15 - 19 999 713 1,4 : 1 1716 41,3 218,1

20 - 24 897 356 2,5 : 1 1254 30,2 91,9

25 - 39 746 224 3,3 : 1 971 23,4 19,8

40 and more 63 21 3,0 : 1 84 2,0 0,8

Unknown 26 12 2,2 : 1 41 1,0 *

Total 2788 1361 2,0 : 1 4158 100 26,0

Women in treatment in the Czech Republic - 2003 The age distribution of treated heroin and Pervitin users

according to sexAll Pervitin users in the Czech Republic in the year 2003 (Prevalence)

All Pervitin users in Prague in the year 2003 (Prevalence)

Age group Men Women Men : women

ratio Total %

Prevalence of women / 100 000 women

Under 15 0 1 0 : 1 1 0,2 1,4 15 - 19 45 101 0,4 : 1 146 25,3 311,5

20 - 24 75 86 0,9 : 1 161 27,9 201,0

25 - 39 148 83 1,8 : 1 231 40,0 63,2

40 and more 27 6 4,5 : 1 33 5,7 1,8

Unknown 4 0 * 6 1,0 *

Total 299 277 1,1 : 1 578 100 45,5

Age group Men Women Men : women

ratio Total %

Prevalence of women / 100 000 women

Under 15 4 5 0,8 : 1 9 0,2 0,6 15 - 19 613 672 0,9 : 1 1288 28,7 205,6

20 - 24 1045 555 1,9 : 1 1601 35,7 143,2

25 - 39 1132 310 3,7 : 1 1442 32,1 27,4

40 and more 102 10 10,2 : 1 112 2,5 0,4

Unknown 26 9 2,9 : 1 38 0,8 *

Total 2922 1561 1,9 : 1 4490 100 29,8

Women in treatment in the Czech Republic 1995 – 2003Trends of the number and of the share

of first treated men and women

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

1995 1996 1997 1998 1999 2000 2001 2002 2003

Men Women

0

500

1000

1500

2000

2500

3000

3500

4000

4500

5000

1995 1996 1997 1998 1999 2000 2001 2002 2003

Num

ber o

f per

sons

Men Women

Women in treatment in the Czech Republic - 2003The share of men and women

according to groups of primary drug

0%

20%

40%

60%

80%

100%

Heroin, opiatesPervitin, stimulants

Cannabinoids

HallucinogensVolatile inhalants

Hypnotics, sedatives

Other substances

Total

Men Women

First treated clients

0%

20%

40%

60%

80%

100%

Heroin, opiatesPervitin, stimulants

Cannabinoids

HallucinogensVolatile inhalants

Hypnotics, sedatives

Other substances

Total

Men Women

All treated clients

Women in treatment in the Czech Republic – 2003 Groups of primary drug according to sex

Cannabinoids (18,96%)Hallucinogens (0,07%)Volatile inhalants (1,10%)Hypnotics, sedatives (1,40%)Other substances (0,59%)Unknown (0,00%)

Heroin, opiates (14,70%)Pervitin, stimulants (63,19%)

Women - FTDCannabinoids (13,30%)

Hallucinogens (0,11%)Volatile inhalants (0,94%)Hypnotics, sedatives (1,66%)Other substances (0,45%)Unknown (0,23%)

Heroin, opiates (23,13%)Pervitin, stimulants (60,17%)

Women - Prevalence

Cannabinoids (25,85%)

Hallucinogens (0,54%)Volatile inhalants (3,61%)

Hypnotics, sedatives (0,79%)Other substances (0,39%)Unknown (0,21%)

Heroin, opiates (16,30%)

Pervitin, stimulants (52,31%)

Men - FTD

Cannabinoids (17,89%)Hallucinogens (0,44%)Volatile inhalants (3,42%)Hypnotics, sedatives (1,02%)Other substances (0,43%)Unknown (0,22%)

Heroin, opiates (25,88%)

Pervitin, stimulants (50,70%)

Men - Prevalence

Women in treatment in the Czech Republic, 1995 - 2003 Number of first treated women with drug use

according to groups of primary drug

0

200

400

600

800

1000

1200

1400

1600

1995 1996 1997 1998 1999 2000 2001 2002 2003

Num

ber

of w

omen

Heroin, opiates Pervitin, stimulants Cannabis Hallucinogens Volatile inhalants

Women in treatment in the Czech Republic – 2003Treated drug users according to the age

<15 (2,04%)

15-19 (35,83%)

Unknown (0,93%)40 and more (2,26%)

25-39 (26,76%)

20-24 (32,17%)

<15 (2,57%)Unknown (0,88%)

40 and more (1,54%)25-39 (16,46%)

20-24 (26,16%)15-19 (52,39%)

<15 (1,21%)

15-19 (23,63%)

Unknown (0,73%)40 and more (3,55%)

25-39 (36,52%)

20-24 (34,36%)

<15 (1,44%)

15-19 (39,38%)

Unknown (0,60%)40 and more (1,81%)

25-39 (22,07%)

20-24 (34,69%)

All treated clients

Men:

Men:

Women:

Women:First treated clients

Women in treatment in the Czech Republic – 2003Treated drug users according to the labour status and sex

Regular employment (10,36%)

Unemployed (34,97%)

Unknown (1,91%)Other (2,13%)

Economically inactive (3,31%)

Pupil/Student (47,32%)

Women - FTD

Regular employment (11,94%)

Unknown (3,74%)Other (2,80%)

Economically inactive (4,23%)

Pupil/Student (34,01%)

Unemployed (43,27%)

Women - Prevalence

Regular employment (14,52%)

Unknown (3,83%)Other (1,89%)

Economically inactive (1,32%)

Pupil/Student (27,39%)

Unemployed (51,05%)

Men - FTD

Regular employment (15,30%)

Unknown (4,26%)Other (2,57%)

Economically inactive (2,44%)

Pupil/Student (17,41%)

Unemployed (58,02%)

Men - Prevalence

Women in treatment in the Czech Republic - 2003The number of women and the share of primary drugs

according to age groups

0

200

400

600

800

1000

1200

Num

ber

of w

omen

Under 15 15-19 20-24 25-39 40 and

more

Unknown

Age groups

Heroin, opiates Pervitin, stimulants Cannabinoids Hallucinogens

Volatile inhalants Hypnotics, sedatives Other substances Unknown

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Under 15 15-19 20-24 25-39 40 and

more

Unknown

Age groups

Heroin, opiates Pervitin, stimulants Cannabinoids Hallucinogens

Volatile inhalants Hypnotics, sedatives Other substances Unknown

Women in treatment in the Czech Republic, 1995 - 2003 First treated women with drug use

according to age groups

0%

20%

40%

60%

80%

100%

1995 1996 1997 1998 1999 2000 2001 2002 2003

under 15 15-19 20-24 25-39 40 and more unknown

Women in treatment in the Czech Republic – 2003Groups of primary drug according to regions - Prevalence

0

50

100

150

200

250

300

Nu

mb

er o

f w

om

en

PragueCentral Bohemia

Southern Bohemia

PlzenCarlsbad

Usti nad Labem

LiberecHradec Kralove

Pardubice

JihlavaSouth Moravia

Olomouc

ZlinMoravskoslezsky

HallucinogensOther substances

Volatile inhalantsCannabis

Heroin,opiatesPervitin,stimul.

Women in treatment in the Czech Republic – 2003Groups of primary drug according to regions - FTD

0

20

40

60

80

100

120

140

Nu

mb

er o

f w

om

en

PragueCentral Bohemia

Southern Bohemia

PlzenCarlsbad

Usti nad Labem

LiberecHradec Kralove

Pardubice

JihlavaSouth Moravia

Olomouc

ZlinMoravskoslezsky

HallucinogensOther substances

Volatile inhalantsCannabis

Heroin,opiatesPervitin,stimul.

Women in treatment in the Czech Republic – 2003 Average age of treated clients according to sex

16

17

18

19

20

21

22

23

24

25

26

Ag

e

Heroin Pervitin Marihuana Toluen, other inhalants

FTD - Men FTD - Women Prevalence - Men Prevalence - Women

Women in treatment in the Czech Republic – 2003Route of administration of primary drug according to sex

Other / Unknown (0,81%)Inhalation (13,30%)

Smoking (20,87%)

Oral (3,38%)

Inject (61,65%)

Women - FTD

Other / Unknown (1,51%)Inhalation (10,20%)

Smoking (15,00%)

Oral (4,12%)

Inject (69,16%)

Women - Prevalence

Other / Unknown (1,30%)Inhalation (11,02%)

Smoking (28,45%)

Oral (2,01%)

Inject (57,21%)

Men - FTD

Other / Unknown (1,45%)Inhalation (10,77%)

Smoking (19,08%)

Oral (3,05%) Inject (65,66%)

Men - Prevalence

Women in treatment in the Czech Republic – 2003Primary and secondary drugs used by women

FTD Prevalence

0 400 800 1200 1600 2000 Number of persons

Subutex

Psilocybine

metadon

brown

Other substances

Cocaine

Hypnotics, sedatives

LSD

Benzodiazepines

Other opiates

Volatile inhalants

Alcohol with drug

Ecstasy

Heroin

Marihuana

Pervitin

Primary drug Secondary drug

Note: Only drugs used by 15 and more women.

0 200 400 600 800 1000 Number of persons

Subutex

Psilocybine

metadon

brown

Other substances

Cocaine

Hypnotics, sedatives

LSD

Benzodiazepines

Other opiates

Volatile inhalants

Alcohol with drug

Ecstasy

Heroin

Marihuana

Pervitin

Primary drug Secondary drug

Women in treatment in the Czech RepublicCONCLUSIONS:

• The highest number of treated women is in the age group 15 – 19 years

• The men : women ratio is lowest in both youngest age groups, in pervitin users in the Czech Republic is lower then 1 : 1 (in Prague in 3 youngest age groups)

• The trend of number of treated women is still increasing

• Treated women use pervitin more often then men

• Treated women are younger then men (55 % of all treated women are younger then 20 years) and they are more commonly in category „pupil / student“

• The share of pervitin use and heroin use among women grows with older age group; the share of cannabinoids use decreases

• The average age of treated women using heroin and opiates is about two years lower in comparison with men, in pervitin the difference is 3,5 years

• The share of treated women with inject administration of drug is about 4 % higher in comparison with men

Thanks for your attention!